Xvivo Perfusion: Q1 preview
Xvivo is scheduled to release its first-quarter earnings results tomorrow before the stock market opens. Following the release, the company will host a telephone conference at 11:30 a. m. CET.
In line with guidance, we expect to see a significant impact from the coronavirus outbreak in Q1. However, we argue that Xvivo is well positioned in the medtech sector and believe that the effect will be short-term.